Cite
HARVARD Citation
Zhao, J. et al. (2020). Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib. Lung cancer. pp. 114-118. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhao, J. et al. (2020). Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib. Lung cancer. pp. 114-118. [Online].